Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
Companies
» Company Monitoring Page for Eli-Lilly
Company Monitoring Page for Eli-Lilly
latest headlines for company on cafepharma
Eli Lilly expands cancer tie-up in fast-growing China market
Yahoo/Reuters
Mon, 10/12/15 - 09:15 am
Tags:
Eli Lilly
,
China
,
Innovent Biologics
Lilly Halts Cholesterol Drug, Losing a Potential Blockbuster
Bloomberg
Mon, 10/12/15 - 09:05 am
Tags:
Eli Lilly
,
clinical trials
,
evacetrapib
3 ADHD Treatment Makers to Watch
Motley Fool
Mon, 10/12/15 - 08:49 am
Tags:
ADHD
,
Shire
,
JNJ
,
Eli Lilly
Lilly buys rights to intranasal diabetes treatment
Marketwatch
Sat, 10/10/15 - 09:08 am
Tags:
Eli Lilly
,
diabetes
,
Locemia Solutions
Why Cholesterol and Alzheimer’s Could Drive Eli Lilly Shares Much Higher
24/7 Wall St
Fri, 10/9/15 - 03:56 pm
Tags:
Eli Lilly
,
solanezumab
,
evacetrapib
,
Alzheimer's disease
An inside look at Lilly's NYC expansion & focus on cancer immunotherapy
BioPharma Dive
Fri, 10/9/15 - 10:37 am
Tags:
Eli Lilly
,
cancer immunotherapy
,
NYC
Oncologists' pricing pushback mounts as docs snub costly me-too drugs
Fierce Pharma
Fri, 10/9/15 - 10:10 am
Tags:
oncologists
,
drug pricing
,
me-too drugs
,
Cyramza
,
Eli Lilly
Lilly Receives FDA Breakthrough Therapy Designation for Abemaciclib - a CDK 4 and 6 Inhibitor - in Advanced Breast Cancer
Yahoo
Thu, 10/8/15 - 09:13 am
Tags:
Eli Lilly
,
abemaciclib
,
advanced breast cancer
,
FDA
,
breakthrough therapies
Payers want new guidelines, more data before easing access to diabetes' CV star Jardiance
Fierce Pharma
Mon, 10/5/15 - 05:52 pm
Tags:
payer negotiation
,
Jardiance
,
diabetes
,
Eli Lilly
,
Boehringer Ingelheim
Did Eli Lilly Just Get a Leg Up on Johnson & Johnson?
Motley Fool
Tue, 09/29/15 - 10:28 pm
Tags:
Eli Lilly
,
JNJ
,
Jardiance
,
Invokana
,
diabetes
Zosano loses its big Eli Lilly deal, and its stock is eviscerated
Fierce Biotech
Tue, 09/29/15 - 02:20 pm
Tags:
Zosano
,
Eli Lilly
,
ZP-PTH
,
osteoporosis
Lilly, Incyte rheumatoid arthritis drug succeeds in late-stage study
Yahoo/Reuters
Tue, 09/29/15 - 09:14 am
Tags:
Eli Lilly
,
Incyte
,
rheumatoid arthritis
,
baricitinib
Sanofi says reaches patent deal with Eli Lilly on Lantus SoloSTAR
Yahoo/Reuters
Mon, 09/28/15 - 10:13 am
Tags:
Sanofi
,
Eli Lilly
,
patents
,
diabetes
,
Lantus SoloSTAR
What’s the Outlook for Eli Lilly?
Yahoo/Market Realist
Tue, 09/22/15 - 09:54 am
Tags:
Eli Lilly
Eli Lilly Officially Puts Merck on Notice
Motley Fool
Tue, 09/22/15 - 09:50 am
Tags:
Eli Lilly
,
Merck
,
Jardiance
,
diabetes
,
Boehringer Ingelheim
,
Januvia
Lilly shares rally to near 15-year high on diabetes drug study results
Marketwatch
Thu, 09/17/15 - 05:27 pm
Tags:
Eli Lilly
,
diabetes
,
Jardiance
Pharma Deal-Making: In The Pink Of Health
Seeking Alpha
Wed, 09/16/15 - 10:26 am
Tags:
M&A
,
Baxalta
,
GSK
,
JNJ
,
Eli Lilly
,
Novartis
,
Perrigo
,
Shire
Lilly boosting size of Kendall Square innovation center
BioPharma Dive
Mon, 09/14/15 - 05:58 pm
Tags:
Eli Lilly
,
R&D
,
innovation
Diabetes rivalries get more complicated with new FDA warning on J&J's Invokana
Fierce Pharma Marketing
Mon, 09/14/15 - 11:01 am
Tags:
diabetes
,
FDA
,
Invokana
,
JNJ
,
Jardiance
,
Boehringer Ingelheim
,
Eli Lilly
Big Pharma's 3 Most Perilous Pipelines
Motley Fool
Sat, 09/12/15 - 01:45 pm
Tags:
Merck
,
GSK
,
Eli Lilly
Pages
« first
‹ previous
…
75
76
77
78
79
80
81
82
83
…
next ›
last »
last 30 twitter posts
current feelings about your job
job rating
*
1 - I hate my job
2
3
4
5
6
7 - I love my job
Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
please tell us why
*
your industry
*
your job title (optional)
your company
*
published
N/A
published
not published
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
cafepharma is a: rock, tree, site
*
Fill in the blank.